In the mice injected with A375-CD1d tumor cells and PBMC-iNKT-FG cells, the tumor-localized injection of αGC efficiently recruited PBMC-iNKT-FG cells to tumor sites; the cell signal from the tumor sites increased through the first two weeks, reached a peak around day 13, and then slowly decreased. Here, CD1D is linked to neoplasm.